Our cases underwent conventional TACE (cTACE) therapy. Depending on the reserved liver function and tumor location, a 2.7 F microcatheter was injected via subsegmental or segmental feeding arteries. Chemoembolization was performed using intra-arterial pirarubicin (20–60 mg), oxaliplatin (200 mg), and lipiodol (5–20 ml), followed by injection of gelatin sponge particles until arterial flow was significantly reduced. The amount of emulsion injection was determined by measuring the tumor volume. Furthermore, TACE was repeated based on residual detection and follow-up examinations. Supportive care was provided when patients were unsuitable for receiving subsequent TACE therapy. Every TACE cycle was implemented via interventional radiologists who had >5 years of experience (23 (link)).
Free full text: Click here
